1. Home
  2. ANIX vs MIND Comparison

ANIX vs MIND Comparison

Compare ANIX & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.97

Market Cap

102.6M

Sector

Health Care

ML Signal

HOLD

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$6.81

Market Cap

83.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
MIND
Founded
1982
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
102.6M
83.4M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ANIX
MIND
Price
$2.97
$6.81
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
113.0K
222.2K
Earning Date
05-27-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
N/A
Revenue This Year
N/A
$23.31
Revenue Next Year
N/A
$1.01
P/E Ratio
N/A
$22.27
Revenue Growth
N/A
N/A
52 Week Low
$2.44
$5.51
52 Week High
$5.46
$14.50

Technical Indicators

Market Signals
Indicator
ANIX
MIND
Relative Strength Index (RSI) 51.78 46.77
Support Level $2.74 $5.92
Resistance Level $3.11 $9.22
Average True Range (ATR) 0.18 0.35
MACD -0.01 0.09
Stochastic Oscillator 36.88 84.52

Price Performance

Historical Comparison
ANIX
MIND

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

Share on Social Networks: